Medicare Coverage Appeals Final Rule Expands Beneficiary Rights – CMS
This article was originally published in The Gray Sheet
Executive Summary
Coverage decision appeals by individual Medicare beneficiaries may have "implications" for future coverage of a device for all beneficiaries under CMS' final appeals rule, the agency maintains
You may also be interested in...
Visudyne/PDT Treatment “More Effective” Than Placebo – MCAC
Coverage of ocular photodynamic therapy with QLT/Novartis' Visudyne (verteporfin) in patients who have age-related macular degeneration and occult lesions with no classic choroidal neovascularization (CNV) should be restricted to those with small lesions, according to several MCAC panel members
CMS Coverage Appeals Proposed Rule Needs Substantial Revision – AdvaMed
The Centers for Medicare & Medicaid Services should refrain from adopting its Aug. 22 proposed rule on review of national and local coverage determinations, AdvaMed contends in Oct. 21 comments to the agency
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.